Another Fluoroquinolone Approved


The FDA has approved a new fluoroquinolone antibiotic indicated for adults with acute bacterial skin and skin structure infections (ABSSSI) caused by specific gram-negative or gram-positive bacteria including methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.